Literature DB >> 28454259

Intentional marginal resection of periosteal osteosarcoma in combination with neoadjuvant chemotherapy: A report of two cases and a review of the literature.

Yu Chen1, Song-Feng Xu1, Ming Xu1, Xiu-Chun Yu1.   

Abstract

A wide resection of the tumor with or without chemotherapy is the treatment of choice for periosteal osteosarcoma (PO) of the extremities, however, post-operative limb function and quality of life could be compromised. The present study reports two cases of 14-year-old boys who presented with progressively enlarging masses in their right knee regions. Computed tomography and magnetic resonance imaging scans indicated a fusiform space-occupying mass encircling the bone cortex, with stippled calcification. A diagnosis of PO was suspected. The histological findings confirmed the diagnosis of intermediate PO. Pre-operative chemotherapies were started, and good responses were detected by clinical evaluation and histological findings. Surgeries preserving the functional structures, including neurovascular bundles, tendons, muscles and epiphyses, were performed, followed by routine chemotherapy. The two patients experienced disease-free survival with follow-up times of 37 and 108 months, respectively. The patients were satisfied with the results of the treatment and they returned to normal life activities. These two cases indicated that a marginal resection of the tumor in conjunction with effective neoadjuvant chemotherapy may be an ideal alternative treatment for intermediate PO, since survival along with well-preserved limb function could be guaranteed. By contrast, a wide excision could result in the loss of limb function.

Entities:  

Keywords:  marginal resection; neoadjuvant chemotherapy; periosteal osteosarcoma

Year:  2017        PMID: 28454259      PMCID: PMC5403556          DOI: 10.3892/ol.2017.5556

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  25 in total

1.  Periosteal osteosarcoma of the calcaneum: a case report.

Authors:  Daljit Singh; Ramesh Sen; Susheel Chaudhary; Sujit Kumar Tripathy
Journal:  Foot Ankle Spec       Date:  2012-02-15

2.  Periosteal osteosarcoma--a European review of outcome.

Authors:  Robert J Grimer; Stefan Bielack; Silke Flege; Stephen R Cannon; Gunnar Foleras; Ivan Andreeff; Todor Sokolov; Antonie Taminiau; Martin Dominkus; Mikel San-Julian; Yehuda Kollender; Georg Gosheger
Journal:  Eur J Cancer       Date:  2005-11-14       Impact factor: 9.162

3.  Caffeine-assisted chemotherapy and minimized tumor excision for nonmetastatic osteosarcoma.

Authors:  H Tsuchiya; K Tomita; Y Mori; N Asada; T Morinaga; S Kitano; N Yamamoto
Journal:  Anticancer Res       Date:  1998 Jan-Feb       Impact factor: 2.480

4.  Neoadjuvant chemotherapy of osteosarcoma: results of a randomized cooperative trial (COSS-82) with salvage chemotherapy based on histological tumor response.

Authors:  K Winkler; G Beron; G Delling; U Heise; H Kabisch; C Purfürst; J Berger; J Ritter; H Jürgens; V Gerein
Journal:  J Clin Oncol       Date:  1988-02       Impact factor: 44.544

5.  The clinical value of CXCR4, HER2 and CD44 in human osteosarcoma: A pilot study.

Authors:  Qiong Ma; Yong Zhou; Baoan Ma; Xiang Chen; Yanhua Wen; Yunyan Liu; Qingyu Fan; Xiuchun Qiu
Journal:  Oncol Lett       Date:  2012-01-09       Impact factor: 2.967

6.  Treatment of osteosarcoma of the extremities with the T-10 protocol, with emphasis on the effects of preoperative chemotherapy with single-agent high-dose methotrexate: a Scandinavian Sarcoma Group study.

Authors:  G Saeter; T A Alvegård; I Elomaa; A E Stenwig; T Holmström; O P Solheim
Journal:  J Clin Oncol       Date:  1991-10       Impact factor: 44.544

7.  Marginal excision for osteosarcoma with caffeine assisted chemotherapy.

Authors:  H Tsuchiya; K Tomita; Y Mori; N Asada; N Yamamoto
Journal:  Clin Orthop Relat Res       Date:  1999-01       Impact factor: 4.176

8.  Osteosarcomas arising on the surfaces of long bones.

Authors:  F Schajowicz; M H McGuire; E Santini Araujo; D L Muscolo; S Gitelis
Journal:  J Bone Joint Surg Am       Date:  1988-04       Impact factor: 5.284

Review 9.  Grading of bone tumors.

Authors:  K K Unni; D C Dahlin
Journal:  Semin Diagn Pathol       Date:  1984-08       Impact factor: 3.464

10.  Periosteal Osteosarcoma: A Review of 17 Cases with Mean Follow-up of 52 Months.

Authors:  Matthew P Revell; Neeta Deshmukh; Robert J Grimer; Simon R Carter; Roger M Tillman
Journal:  Sarcoma       Date:  2002
View more
  3 in total

1.  miR-143-3p inhibits the proliferation, migration and invasion in osteosarcoma by targeting FOSL2.

Authors:  Xiangran Sun; Guo Dai; Ling Yu; Qingzhu Hu; Jingteng Chen; Weichun Guo
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

2.  miR-210 promotes human osteosarcoma cell migration and invasion by targeting FGFRL1.

Authors:  Xiangjun Liu; Chengfeng Zhang; Cunhua Wang; Jianwei Sun; Deliang Wang; Yansheng Zhao; Xiaohui Xu
Journal:  Oncol Lett       Date:  2018-06-11       Impact factor: 2.967

3.  Hsa_circ_0051079 functions as an oncogene by regulating miR-26a-5p/TGF-β1 in osteosarcoma.

Authors:  Zuojun Zhang; Ming Zhao; Guojie Wang
Journal:  Cell Biosci       Date:  2019-11-29       Impact factor: 7.133

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.